116 related articles for article (PubMed ID: 38650158)
1. Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy.
Lv J; Zhang J; Wu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):254-259. PubMed ID: 38650158
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of kisspeptin-1, matrix metalloproteinase-2 and vascular endothelial growth factor in tissue of colon cancer].
Wang W; Qi Y; Xu Q; Ren H
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):415-7. PubMed ID: 27005549
[TBL] [Abstract][Full Text] [Related]
3. [Relationship and clinical significance of KiSS-1, nuclear factor kappa B (NF-kappaB), p50, and matrix metalloproteinase 9 expression in breast cancer].
Yi X; Li CY; Zhang SH; Wang XH; Li ZQ; Yang F
Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):238-42. PubMed ID: 18844032
[TBL] [Abstract][Full Text] [Related]
4. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.
Li HC; Cao DC; Liu Y; Hou YF; Wu J; Lu JS; Di GH; Liu G; Li FM; Ou ZL; Jie C; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2004 Nov; 88(1):75-85. PubMed ID: 15538048
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression.
Skerenova M; Mikulova V; Capoun O; Zima T; Tesarova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):272-280. PubMed ID: 28529342
[TBL] [Abstract][Full Text] [Related]
7. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
Chen Y; Wang X; Chen G; Dong C; Zhang D
PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
[TBL] [Abstract][Full Text] [Related]
8. KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer.
Moya P; Esteban S; Fernandez-Suarez A; Maestro M; Morente M; Sánchez-Carbayo M
Tumour Biol; 2013 Feb; 34(1):471-9. PubMed ID: 23132294
[TBL] [Abstract][Full Text] [Related]
9. The expression of matrix metalloproteinase 2, 9 and 11 in Ethiopian breast cancer patients.
Belachew EB; Desta AF; Deneke DB; Gebremariam TY; Tefera DA; Atire FA; Alemayehu DH; Seyoum T; Bauer M; Girma S; Sewasew DT; Kantelhardt EJ; Tessema TS; Howe R
BMC Res Notes; 2023 Oct; 16(1):253. PubMed ID: 37798646
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.
Zhang B; Cao X; Liu Y; Cao W; Zhang F; Zhang S; Li H; Ning L; Fu L; Niu Y; Niu R; Sun B; Hao X
BMC Cancer; 2008 Mar; 8():83. PubMed ID: 18373849
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma.
Hirvonen R; Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T
Breast Cancer Res Treat; 2003 Jan; 77(1):85-91. PubMed ID: 12602907
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
[TBL] [Abstract][Full Text] [Related]
13. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma.
Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T
Br J Cancer; 2003 Oct; 89(7):1270-5. PubMed ID: 14520459
[TBL] [Abstract][Full Text] [Related]
16. Kiss-1/GPR54 protein expression in breast cancer.
Papaoiconomou E; Lymperi M; Petraki C; Philippou A; Msaouel P; Michalopoulou F; Kafiri G; Vassilakos G; Zografos G; Koutsilieris M
Anticancer Res; 2014 Mar; 34(3):1401-7. PubMed ID: 24596387
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue.
Mohammad MA; Zeeneldin AA; Abd Elmageed ZY; Khalil EH; Mahdy SM; Sharada HM; Sharawy SK; Abdel-Wahab AH
Mol Cell Biochem; 2012 Jul; 366(1-2):269-75. PubMed ID: 22527932
[TBL] [Abstract][Full Text] [Related]
18. The Predictive Role of MMP-2, MMP-9, TIMP-1 and TIMP-2 Serum Levels in the Complete Response of the Tumor to Chemotherapy in Breast Cancer Patients.
Ozdemir K; Zengin I; Guney Eskiler G; Kocer HB; Ozkan AD; Demiray T; Sahin EO
J Invest Surg; 2022 Jul; 35(7):1544-1550. PubMed ID: 35636767
[TBL] [Abstract][Full Text] [Related]
19. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
Incorvaia L; Badalamenti G; Rini G; Arcara C; Fricano S; Sferrazza C; Di Trapani D; Gebbia N; Leto G
Anticancer Res; 2007; 27(3B):1519-25. PubMed ID: 17595770
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of KiSS-1 in placenta of preeclampsia and its effect on trophoblast.
Zhang H; Long Q; Ling L; Gao A; Li H; Lin Q
Reprod Biol; 2011 Jul; 11(2):99-115. PubMed ID: 21804632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
